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Aims: To describe symptoms and lung function in patients registered with asthma or chronic 
obstructive pulmonary disease (COPD) in primary care and to examine how spirometry findings 
fit with general practitioners’ (GPs) diagnoses.
Methods: Patients aged $40 years with a diagnosis of asthma or COPD registered in the 
electronic medical record during the previous 5 years were recruited at seven GP offices in 
Norway in 2009–2010. Registered diagnosis, spirometry results, comorbidity, and reported 
symptoms were compared.
Results: Among 376 patients, 62% were women. Based on Global Initiative for Chronic 
Obstructive Lung Diseases criteria, a spirometry diagnosis of COPD could be made in 68.1% 
of the patients with a previous COPD diagnosis and in 17.1% of those diagnosed with asthma 
only (P < 0.001). The κ agreement between last clinical diagnosis of COPD and COPD based on 
spirometry was 0.50. A restrictive spirometry pattern was found in 19.4% and more frequently 
in patients diagnosed with both asthma and COPD (23.9%) than in patients diagnosed with 
COPD only (6.8%, P = 0.003).
Conclusion: The ability of GPs to differentiate between asthma and COPD seems to have 
considerably improved during the last decade, probably due to the dissemination of spirom-
etry and guidelines for COPD diagnosis. A diagnosis of COPD that cannot be confirmed by 
spirometry represents a challenge in clinical practice, in particular when a restrictive pattern 
on spirometry is found.
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Introduction
The prevalence of self-reported current asthma was 4.5% in a population-based survey 
among adults in the USA.1 The prevalence of chronic obstructive pulmonary disease 
(COPD) among those aged 40 years or older has been estimated to be 5%–10%.2 
 Considerably higher figures have been found based on spirometry in epidemiologic 
surveys3 than in registrations from medical records.4,5 In a random sample of middle-
aged and elderly subjects from Norway, 3% received medical treatment for COPD 
during 1 year.6 However, these 3% only accounted for one-third of those in the sample 
with spirometry findings indicating COPD according to the Global Initiative for Chronic 
Obstructive Lung Diseases (GOLD) guidelines.7 Medicine for either asthma or COPD 
was dispensed to 8% of Norwegians in 2004.8
Between 1995 and 2004, the yearly registration of COPD in primary care  medical 
records increased among men aged $65 years from 1.5% to 5.0%. At the same time, the 
registration of asthma dropped from 3.2% to 1.9% in the same group.9 This was explained 
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by a change in the use of diagnostic labels, based on increased 
use of spirometry10 and new  diagnostic guidelines.9 A similar 
shift in diagnostic labeling was clearly  demonstrated in a large 
survey of British patients with obstructive lung disease from 
1997 to 2000. Among the patients with a  previous diagnosis 
of asthma, 56% had their diagnosis changed to COPD or 
a combination of the two diseases after being assessed by 
spirometry.11  Tinkelman et al12 also described considerable 
discrepancy between  diagnosis and spirometry results in a 
paper published in 2006, where approximately half of the 
patients with COPD  according to the GOLD criteria were 
diagnosed with asthma.
This is the first presentation of a Norwegian study from 
general practice on asthma and COPD, DIOLUP (Better 
Diagnosis and Treatment in Exacerbations of Obstructive 
Lung Diseases in Primary Care). The aim of this study was 
to describe lung function, symptoms during the stable phase 
of illness, and diagnostic label used in men and women 
aged $40 years. The investigators wanted to evaluate how 
appropriately the diagnostic labels of asthma and COPD 
are used, and explore features of patients who had been 
registered with both diagnoses in the medical record the 
preceding 5 years.
Methods
The study was carried out at seven general practice offices in 
the north and south of Norway. The practices were not randomly 
selected but were chosen based on availability of spirometry 
during the previous 5 years and the kind of electronic medi-
cal record used. Out of 43,241 subjects listed at these seven 
offices, 18,931 (43.8%) were aged $40 years. Among these, 
patients with a diagnosis of asthma or COPD who had been 
registered in the 5 years previous to the start of the study were 
identified. From these, a random sample of patients, follow-
ing in alphabetical order, were invited by mail to take part. 
The number invited in each practice was decided based on 
the workload associated with and including each patient, as 
well as the capacity for such tasks at each office. Participation 
implied a baseline examination, including spirometry, during a 
stable phase of disease and, though not dealt with in this study, 
examinations during exacerbations the following 12 months. 
The baseline examinations took place between April 2009 and 
March 2010. The participants were told not to take their regular 
respiratory medication on the examination day.
Registrations
Prior diagnosis of asthma or COPD recorded by a  general 
practitioner (GP) in the electronic medical records 
 during the 5 years before the baseline examination was 
 automatically registered by a software developed by Mediata 
AS  (Tønsberg, Norway). Comorbidities were registered 
by GPs on a  computerized questionnaire on the same 
platform and linked to the medical record. The patients 
registered  smoking and coughing on a separate question-
naire, and questions on respiratory symptoms and quality 
of life items, including shortness of breath, on the Clinical 
COPD Questionnaire, a validated questionnaire.13 Height 
and weight were measured in some patients and were self-
reported in others.
Spirometry
Spirometry was carried out by trained health workers, 
 following European Respiratory Society/American  Thoracic 
Society guidelines,14 using a Spirare SPS310 spirom-
eter (Diagnostica AS, Oslo, Norway). The patients were 
seated, and a nose clip was not used. Postbronchodilator 
 spirometry was carried out 20 minutes after inhalation of 
0.4 mg  salbutamol, and a 12% increase of forced expiratory 
 volume in the first second of expiration (FEV
1
), together with 
a minimum increase of 200 mL, was used as evidence of 
reversibility. The postbronchodilator FEV
1
 and forced vital 
capacity (FVC) were used in the analyses, and the patients 
with a FEV
1
/FVC ratio , 0.7 were classified as COPD 
patients according to GOLD guidelines. In this cohort of 
patients diagnosed with asthma or COPD, asthma was the 
only possible diagnosis when FEV
1
/FVC $ 0.7, but it could 
be regarded as certain only when supported by a positive 
reversibility test. Norwegian reference values for spirometry 
were applied.15
Statistical analyses
Patients were grouped by diagnoses of asthma and COPD 
registered by the GPs in the medical record prior to the 
examination and by spirometry results following GOLD 
criteria.7 Patients with GOLD 3 and GOLD 4 spirometry 
(FEV
1
 , 50% predicted and FEV
1
/FVC ratio , 70%) were 
grouped together, whereas patients with spirometry incom-
patible with COPD according to GOLD guidelines (FEV
1
/
FVC ratio $ 70%) were classified as “restrictive” when 
both FEV
1
% predicted and FVC% predicted were ,80%.16 
Differences among subgroups were analysed by χ2 test and 
Student’s t-test. Agreement in diagnosis was assessed by κ 
statistics. SPSS (v 17.0; SPSS, Inc, Chicago, IL) was used in 
the statistical analyses. A 5% level of statistical  significance 
was used. The study was approved by the Regional  Committee 
for Medical and Health Research Ethics in North Norway.
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Results
Among the 18,931 patients aged $40 years listed at the 
seven practices, 1784 (9.4%) had been registered with a 
diagnosis of asthma or COPD during the previous 5 years 
(the background population, Table 1). A random sample 
of these, 1111, were invited, and 380 (34.2%) accepted 
and took part in the baseline examination. In two patients, 
the GP prescribed antibiotics due to symptoms and signs 
of an acute exacerbation, and these were excluded from 
the  analysis. Also excluded were two patients who did not 
perform postbronchodilator spirometry. Among the 376 
remaining patients, 62.0% were women, and the median age 
was 62 years. The corresponding figures in the background 
population were 60.8% and 61 years (Table 1).
Diagnosis
A diagnosis of asthma had been made during the 5 years 
before baseline in 80.3% and a diagnosis of COPD in 44.1%. 
COPD was most recently registered in 128 patients (34%) 
and in 58 (63%) of the subgroup with both diagnoses, among 
whom eight patients had been registered with both diagnoses 
the same day. Patients diagnosed with asthma only were 
younger (mean age 57.4 years) than those registered with 
COPD (66.7 years, P , 0.001). A single diagnosis of COPD 
was registered more frequently in the background population 
than in the study sample, whereas the opposite was the case 
for the registration of both asthma and COPD (Table 1).
Spirometry
Postbronchodilator spirometry indicating COPD (FEV
1
/
FVC , 0.7) was found in 149 patients (39.6%), in 69 men 
(48.3%) and 80 women (34.3%) (P = 0.007). Before  taking a 
bronchodilator there were 157 patients with FEV
1
/FVC , 0.7. 
Reversibility was detected in 16.8%. Of the patients, 
95.5% expired for 6 seconds or more when performing 
postbronchodilator spirometry. A spirometry diagnosis 
of COPD could be made in 68.1% of the patients with a 
previous COPD diagnosis and in 17.1% of those diagnosed 
with asthma only (P , 0.001). GOLD 3–4 spirometry was 
found 13× more frequently among the patients diagnosed 
with COPD only or with both diagnoses than among those 
diagnosed with asthma only (Table 2). A restrictive pattern 
was found in 19.4% of the patients, and more than three times 
as frequently in the patients diagnosed with both asthma 
and COPD than in the COPD-only group, and with similar 
frequency as in the asthma-only group (Table 2).
Agreement between clinical diagnosis  
and spirometry
Of the 149 patients with FEV
1
/FVC , 0.7, COPD was 
registered in 75.3% and was the latest diagnosis given 
in 63.8%. Conversely, COPD, as the latest diagnosis, 
was confirmed by spirometry in 74.2%. The κ agreement 
between the COPD as the latest diagnosis in the medical 
record and COPD diagnosis based on spirometry was 0.50 
(Table 3).
Smoking and comorbidities
The patients with a diagnosis of asthma only were more fre-
quently never smokers and less frequently previous smokers 
compared with the patients diagnosed with COPD (Table 4). 
Table 1 Gender, age, and diagnosis in the study population of 
376 patients and in the background population of 1781 patients 
aged $40 years diagnosed with asthma or chronic obstructive 
pulmonary disease (COPD) in primary care
Study  
population 
n = 376 (%)
Background 
population 
n = 1781 (%)
Women 233 (62.0) 1083 (60.8)
Men 143 (38.0) 698 (39.2)
Age (years, median) 62 61
Diagnostic category
Asthma 302 (80.3) 1298 (72.9)
COPD 166 (44.1) 720 (40.4)
Asthma, no COPD 210 (55.9) 1061 (59.6)
COPD, no asthma 74 (19.7) 483 (27.1)a
Both asthma and COPD 92 (24.5) 237 (13.3)a
Note: aThe difference in frequency between study sample and the nonparticipating 
part of the background population is statistically significant, P , 0.001.
Table 2 Age and lung function by diagnosis registered in the 
medical record in 376 patients aged $40 years diagnosed with 
asthma or chronic obstructive pulmonary disease (COPD) in 
primary care
Asthma only 
n = 210 (%)
COPD only 
n = 74 (%)
Both asthma 
and COPD 
n = 92 (%)
Age $ 65 years 26.7a 62.2 54.3
Spirometry
Normal (n = 154) 61.0a 13.5 17.4
Restrictivea (n = 73) 21.9 6.8c 23.9
GOLD 1 (n = 18) 2.4b 14.9 2.2
GOLD 2 (n = 87) 12.9a 33.8 38.0
GOLD 3–4 (n = 44) 1.9a 31.1 18.5
Reversibility ($12% 
and .0.2 L, n = 63)
14.3 17.6 21.7
Notes: aThe difference between the asthma group and the two COPD groups is 
statistically significant, P , 0.001; bthe difference between the asthma group and the 
two COPD groups is statistically significant, P = 0.01; cthe difference between the 
two COPD groups is statistically significant, P = 0.003.
Abbreviation: GOLD, Global Initiative for Chronic Obstructive Lung Diseases.
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Diabetes, hypertension, atopic eczema, and allergic rhinitis 
were more common among the patients with both diagnoses 
than in those with a single diagnosis of COPD (Table 4). 
Obesity (body mass index $ 30) was found in 47.1% in the 
restrictive group significantly more frequently (P , 0.001) 
than among the patients with obstructive (FEV
1
/FVC , 0.7) 
or normal spirometry, who had frequencies of 13.2% and 
22.8%, respectively.
Symptoms
There were only minor differences in reported coughing 
and phlegm between the three diagnostic groups (Table 4). 
Shortness of breath during physical activity was the symptom 
most frequently reported, according to the registrations on 
the Clinical COPD Questionnaire –51% had this symptom 
several times or more in the last week. Shortness of breath 
during physical activity “a great many times” or “almost all 
of the time” was reported by 18.6% and more frequently in 
the GOLD 3–4 group than in the other spirometry groups 
(P , 0001, Figure 1). Such severe shortness of breath was 
reported significantly more frequently by the patients who 
had been diagnosed with COPD compared with those with 
a single diagnosis of asthma (P , 0.001, Figure 1).
Discussion
The accuracy of the COPD diagnosis
The registration of COPD in 64% of the patients with FEV
1
/
FVC , 0.7 represents an improvement in detection of 
COPD in routine care compared with previous studies.11,12,17 
In a similar study by Tinkelman et al,12 the corresponding 
detection rate was 42.9%. In the present study, 17.1% of the 
patients diagnosed with asthma only had COPD according 
to spirometry, whereas in the CADRE (COPD and Asthma 
Diagnostic/Management Reassessment) study,11 56% of 
asthma patients could be labeled with a COPD diagnosis 
after spirometry. Overdiagnosis of COPD was a smaller 
problem in the present study than in previous studies. Of the 
128 patients who had been diagnosed with COPD the last 
time asthma or COPD was registered in the medical records, 
diagnosis was confirmed by spirometry in 74.2%, whereas 
the frequency was 48.4% in Tinkelman et al’s12 study. This 
improvement in diagnostic accuracy is not surprising, taking 
into account the strong increase in the use of spirometry 
in primary care9,10 and the dissemination of diagnostic 
guidelines promoted by, among others, the GOLD initiative. 
But this improvement should not be ascribed to the GPs 
alone. Many patients have consulted pulmonologists and 
had their diagnosis adjusted by them. In the present study, 
a κ agreement of 0.50 was found, which is characterized 
as “moderate” by Altman.18 Although a further decrease in 
misdiagnosis should be pursued, a complete agreement is 
probably neither possible nor wanted. The GOLD criteria 
for diagnosing COPD should be regarded as a guide and not 
as a strict rule.19,20 The high frequency of previous smoking, 
Table 3 Agreement between chronic obstructive pulmonary disease 
(COPD) as the diagnosis most recently registered in the medical 
record before the examination, and the diagnosis indicated by 
spirometry in 376 patients aged 40 years or more diagnosed with 
asthma or COPD in primary care (κ 0.50 [standard deviation 0.05])
COPD according to spirometry
Yes No Total
COPD registered in medical record
Yes 95 33 128
No 54 194 248
Total 149 227 376
Table 4 Smoking, comorbidity, and coughing by diagnosis 
registered in the medical record previous to the study in 
376 patients aged $40 years diagnosed with asthma or chronic 
obstructive pulmonary disease (COPD) in primary care
Asthma  
only 
n = 210 (%)
COPD  
only 
n = 74 (%)
Both asthma 
and COPD 
n = 92 (%)
Smoking habit
Current smoker  
(n = 103)
23.8 27.0 35.9
Previous smoker  
(n = 162)
36.7a 55.4 47.8




Obesity (body  
mass index $ 30)d
25.4 15.9 27.1
Cardiovascular  
disease (n = 122)
22.9b 51.4 39.1
Diabetes (n = 31) 4.8 5.4 18.5c
On antihypertensives  
(n = 138)
30.0 36.5 52.2c
Atopic eczema  
(n = 56)
19.0 4.1 14.1c




Usually not (n = 117) 32.0 36.1 26.4
Usually dry (n = 92) 26.7 25.0 20.9
Usually with phlegm  
(n = 161)
41.3 38.9 52.7
Notes: aThe difference between the asthma group and the two COPD groups is 
statistically significant, P = 0.005; bthe difference between the asthma group and the 
two COPD groups is statistically significant, P , 0.001; cthe difference between the 
two COPD groups is statistically significant, P , 0.05; dweight was registered in only 
355 patients.
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cardiovascular disease, and current shortness of breath 
(Table 4, Figure 1) in the patients labeled with COPD may 
indicate a substantial impact of presenting symptoms and 
clinical history in the diagnostic work-up.
Mixed diagnosis
Among the patients who had been registered with both 
asthma and COPD during the previous 5 years, COPD was 
more frequently the last diagnosis of the two. This probably 
represents the trend of change in diagnosis from asthma to 
COPD.
There may also be other reasons for alternating between 
the diagnoses of asthma and COPD. Asthma, recognized or 
unrecognized in the health care system, may develop into 
COPD.21 This may, for instance, happen when an asthmatic 
keeps on smoking. A real presence of both diseases is sup-
ported by the relatively high frequency of atopic eczema 
and allergic rhinitis in the subgroup with both diagnoses. 
A tendency to prefer the use of an asthma diagnosis may 
have been strengthened by the reimbursement regulation 
for respiratory medication introduced in Norway in 2006. 
When the study was carried out, costs of inhaled corticoster-
oids and inhaled corticosteroids combined with long-acting 
β
2
-agonists could be reimbursed, as a rule, only in patients 
with a diagnosis of asthma.
A third possible explanation to the use of both diagno-
ses may be related to the GPs’ difficulties in deciding on a 
 diagnosis. Many patients with mixed diagnosis were obese and 
suffered from diabetes. Obesity and metabolic syndrome are 
frequently associated with pulmonary restriction,22 which was 
a common finding in the authors’ patients with mixed  diagnosis. 
A restrictive pattern on the spirogram may also be found in 
congestive heart failure.23 When assessing patients with 
shortness of breath, a restrictive pattern on spirometry may 
indicate obesity or heart failure, instead of asthma or COPD. 
However, a restrictive pattern may also be seen in emphy-
sema, when the residual volume is considerably increased, 
and due to hyperinflation in insufficiently controlled asthma 
and COPD patients.24,25 It has also been reported in asthma 
patients in whom obesity, heart failure, and hyperinflation 
have been ruled out.26
In this study, the patients were seated, as recommended,16 
during spirometry. This practice may reduce the FVC in 
obese people.27 Perhaps some of the obese patients with 
restrictive spirometry could have been diagnosed as obstruc-
tive if the procedure had been carried out standing.
Mixed diagnosis may also reflect frequent visits to the 
practice and consultations with more than one doctor during 
the 5-year period.
Asthma
Asthma was the diagnosis most frequently registered in the 
medical record. Patients diagnosed with asthma and not 
COPD had better lung function and were less bothered by 
shortness of breath than patients diagnosed with COPD. 
This could be expected due to the episodic character of the 
disease and the efficacy of medical treatment.28 The high 
frequency of allergic rhinitis (53.8%, Table 4) indicates the 
impact of comorbidity when a diagnosis of asthma is made.29 
Severe COPD (GOLD 3–4 spirometry) was very infrequent 
in the subgroup with only asthma diagnosis (1.9%), whereas 
15.2% had mild to moderate COPD. Accordingly, spirograms 
obtained during the 5 years before the study could probably 
support a diagnosis of asthma in the great majority of cases. 
In this study, reversibility testing supported a diagnosis of 
asthma in only 14.3%. However, a positive reversibility 
0









Figure 1 Frequency of reporting shortness of breath occurring either a great many times or almost all the time the week before the examination in 371 patients 
aged $40 years diagnosed with asthma or chronic obstructive pulmonary disease (COPD) in primary care.
Abbreviation: GOLD, Global Initiative for Chronic Obstructive Lung Diseases.
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test can be expected only in asthma patients who are not 
adequately treated.28
Strengths and weaknesses
This was a prospective study carried out at dedicated GP 
offices. Missing data have been a minor problem, but the 
quality of the spirometry has probably been better than usual. 
Because the participation rate of the patients invited to the 
study was only 34%, it cannot be assumed that the study sample 
is representative of the background population. Patients who 
had been given a diagnosis of both asthma and COPD partici-
pated much more frequently than those with a single diagnosis 
of COPD. A double diagnosis may, as mentioned previously, 
reflect frequent visits to the practice and, accordingly, a more 
severe illness, also indicated by the high frequency of dyspnea 
in this subgroup (Figure 1). The low participation rate among 
those with a single diagnosis of COPD may reflect that the most 
severely impaired COPD patients, who are frequently hospital-
ized and followed up in secondary care, were less inclined to 
participate. At the other end of the spectrum, patients who had 
once had a diagnosis of asthma or COPD but now felt gener-
ally healthy might also have been less interested in taking part 
and could thus be underrepresented. However, the selection 
biases have probably had little influence on the main findings 
of the study in terms of associations among diagnostic labels, 
spirometry results, and symptoms.
Although the participants were told to meet for the 
baseline examination during a stable phase of their disease, 
some patients were probably not optimally treated. This 
may have led to overdiagnosis of COPD in some cases, 
for instance, among patients who, in reality, suffered from 
asthma. Unsatisfactory performance of spirometry may also 
have had some impact on the results. Although 95.5% of the 
patients expired for more than 6 seconds, a too-low FVC 
was probably attained in some patients. This may have led 
to misclassification of some COPD patients into the normal 
and restrictive groups.
The GP offices chose voluntarily to take part in the study 
and might not be representative of Norwegian practices. 
In 3/7 offices, the participating GPs had a special interest 
in spirometry and obstructive lung diseases. However, the 
κ agreement between clinical diagnosis and spirometry based 
on these three offices was similar (0.48) to that found in the 
other four offices (0.52).
Implications for clinical practice
GPs’ capability of detecting COPD is improving, thanks 
to the dissemination of spirometry and GOLD guidelines 
in primary care. The focus on diagnosing COPD should 
still be strong, due to the evident effect of quitting smoking 
for this disease.7 However, it should be acknowledged that 
some patients suffer from both asthma and COPD, and that 
spirometry does not differentiate between asthma and COPD 
in all cases. Detection of a restrictive spirometry pattern 
may represent a particular challenge, and clinicians should 
probably consider other explanations for shortness of breath 
than asthma and COPD, including obesity, when a restrictive 
pattern is found.
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